Author(s): Burris JF
Abstract Share this page
Abstract Angiotensin converting enzyme (ACE) inhibitors are increasingly important in antihypertensive therapy because of their efficacy, tolerability, and specific benefits in subsets of patients. They are pharmacologically diverse. Whereas most benefits have been proven with older agents (captopril, enalopril), newer agents, such as benazepril, quinapril, and ramipril, offer potential advantages that remain to be proven.
This article was published in J Clin Pharmacol
and referenced in Pharmaceutica Analytica Acta